Squarepoint’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,500
Closed -$218K 4916
2025
Q4
$218K Sell
4,500
-15,100
-77% -$748K ﹤0.01% 3810
2025
Q3
$925K Sell
19,600
-1,200
-6% -$57.9K ﹤0.01% 2755
2025
Q2
$1M Sell
20,800
-6,800
-25% -$347K ﹤0.01% 2647
2025
Q1
$1.53M Sell
27,600
-41,200
-60% -$2.23M ﹤0.01% 2306
2024
Q4
$3.32M Buy
+68,800
New +$3.5M ﹤0.01% 1968

Other funds holding SNY

Squarepoint's SNY Position: Q1 2026 in Review

Squarepoint increased its Sanofi (SNY) stake by 239% in Q1 2026, buying an estimated $3.74M and bringing the position to 113,857 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Squarepoint first reported a position in SNY in Q4 2016 and has held it in 5 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Squarepoint held 113,857 shares of Sanofi worth $3.87M as of Q1 2026.
  • Squarepoint bought 80,291 Sanofi shares in Q1 2026, an estimated $3.74M.
  • Sanofi made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1698 holding.
  • Squarepoint first reported a position in Sanofi in Q4 2016 and has held it in 5 quarters since.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.